It’s time to catch up on some recent headlines from Wisconsin’s innovation community:
—Dianomi Therapeutics, a Madison-based life sciences startup, said it received a $3 million investment from San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND). The investment includes $2 million in equity funding and $1 million in convertible debt financing, according to a Dianomi spokesperson.
As part of the deal, Ligand said it will provide technical and scientific advisory services to Dianomi for a year, and it will receive a tiered royalty of 2 percent or 3 percent of net sales for the first five approved products that use Dianomi’s technology,… Read more »
UNDERWRITERS AND PARTNERS